In order to validate this in osteosarcoma cells, we measured the protein levels of MEK1/2, P-MEK1/2, ERK1/2, and P-ERK1/2 in 143B and U2OS cells that were either depleted or overexpressed with TNK2. This evidence concerns the gene MAPK3 and osteosarcoma.